Biomarkers may be an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
24 Mar, 2022 | 08:17h | UTCCommentary: Biomarkers may improve giant cell arteritis diagnosis – medwireNews
Commentary on Twitter
In our newest paper we investigated biomarkers that aid the diagnosis of Giant Cell Arteritis versus PMR or other mimicing conditions. This time, we worked together with our colleagues in Aarhus, Denmark to measure the biomarkers in 2 independent cohortshttps://t.co/d6PWsGSl2H
— Yannick van Sleen (@SleenYannick) March 11, 2022